14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.401 $0.580 Thursday, 2nd May 2024 VIRI stock ended at $0.421. This is 4.27% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 12.19% from a day low at $0.401 to a day high of $0.450.
90 days $0.280 $0.629
52 weeks $0.280 $2.42

Historical Virios Therapeutics, LLC prices

Date Open High Low Close Volume
May 02, 2024 $0.445 $0.450 $0.401 $0.421 128 761
May 01, 2024 $0.431 $0.460 $0.430 $0.440 22 512
Apr 30, 2024 $0.447 $0.460 $0.435 $0.452 32 417
Apr 29, 2024 $0.455 $0.470 $0.450 $0.470 70 099
Apr 26, 2024 $0.461 $0.475 $0.450 $0.470 38 251
Apr 25, 2024 $0.438 $0.468 $0.430 $0.456 52 844
Apr 24, 2024 $0.419 $0.475 $0.419 $0.425 197 373
Apr 23, 2024 $0.430 $0.445 $0.421 $0.431 61 255
Apr 22, 2024 $0.435 $0.445 $0.401 $0.426 71 774
Apr 19, 2024 $0.459 $0.459 $0.435 $0.436 56 301
Apr 18, 2024 $0.440 $0.450 $0.427 $0.450 59 084
Apr 17, 2024 $0.464 $0.480 $0.450 $0.451 85 885
Apr 16, 2024 $0.457 $0.488 $0.441 $0.452 163 740
Apr 15, 2024 $0.504 $0.529 $0.470 $0.471 164 971
Apr 12, 2024 $0.463 $0.528 $0.463 $0.512 359 261
Apr 11, 2024 $0.451 $0.510 $0.450 $0.480 35 569
Apr 10, 2024 $0.460 $0.479 $0.440 $0.465 134 597
Apr 09, 2024 $0.473 $0.520 $0.460 $0.464 179 232
Apr 08, 2024 $0.470 $0.499 $0.433 $0.451 173 429
Apr 05, 2024 $0.490 $0.490 $0.441 $0.458 234 635
Apr 04, 2024 $0.497 $0.526 $0.480 $0.481 223 917
Apr 03, 2024 $0.560 $0.569 $0.490 $0.492 137 997
Apr 02, 2024 $0.580 $0.580 $0.495 $0.540 273 994
Apr 01, 2024 $0.486 $0.580 $0.480 $0.580 703 345
Mar 28, 2024 $0.490 $0.530 $0.430 $0.479 414 123
Click to get the best stock tips daily for free!

About Virios Therapeutics, LLC

Virios Therapeutics LLC Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, atten... VIRI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT